ProShares Ultra Nasdaq Biotechnology
BIB
#2857
ETF rank
โ‚ฌ86.61 M
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
98,43ย โ‚ฌ
Share price
-1.11%
Change (1 day)
46.31%
Change (1 year)

Expense ratio and fees for ProShares Ultra Nasdaq Biotechnology (BIB)

Expense Ratio

Expense Ratio as of November 2026: 0.95%

Gross Expense Ratio

Gross Expense Ratio as of November 2026: 1.17%

Net Expense Ratio

Net Expense Ratio as of November 2026: 0.95%